Next we revealed the importance of p90RSK activation in tumor vessel hyper-permeability by demonstrating that treatment of tumor bearing mice with the p90RSK specific inhibitor, FMK-MEA, significantly inhibits tumor vessel permeability without affecting tumor vessel morphology. Here, RPS6KA1 is linked to neoplasm.